What Rapid Antigen Testing Is and How Devices DifferRapid antigen testing detects specific proteins — antigens — from a pathogen directly in a patient sample, giving a visible result in minutes without a laboratory. The commonest format is a lateral-flow device: a swab or sample is mixed with a buffer, dripped onto a cassette, and a coloured line appears if the target antigen is present. It answers a simple question quickly: is this person carrying enough of the pathogen right now to be detected.The tests are cheap and fast, which is exactly why they need buying with care. Antigen devices differ widely in sensitivity, sample type, reading method and regulatory status, and a procurement lead has to match those differences to the clinical purpose rather than treating all rapid tests as equivalent.How rapid antigen testing worksA lateral-flow antigen test relies on immunochromatography. The sample, released into a buffer, flows along a nitrocellulose strip by capillary action. It first meets antibodies bound to coloured particles — often gold nanoparticles or coloured latex — that grab any target antigen. The antigen-antibody complex flows on to a test line coated with a second, fixed antibody that captures the complex and concentrates the coloured particles into a visible line. Excess particles continue to a control line, which must appear for the test to be valid, confirming the sample flowed and the reagents worked. No line at the test position means antigen was not detected above the threshold.Because the readout depends on capturing enough antigen, rapid antigen tests are most sensitive when viral or bacterial load is high, and less sensitive at low load. That is the central trade-off against laboratory molecular tests, which amplify genetic material and detect far smaller amounts but take longer and cost more. Understanding this principle is what stops a buyer over- or under-relying on the format.How antigen devices differVisually read lateral-flow cassettesThe simplest devices are read by eye against the printed control line. They need no instrument, suit point-of-care and self-testing, and are the lowest cost per test, but reading is subjective near the detection threshold.Reader-assisted and fluorescence devicesSome antigen tests are read by a small analyser, either interpreting a coloured line objectively or using a fluorescent label that a reader must measure. Reader-based systems reduce subjective interpretation, can improve sensitivity and give a printed or transmitted result, at the cost of an instrument and its throughput.Sample type and targetDevices differ by sample — nasal, nasopharyngeal, throat, saliva — and by target pathogen, from respiratory viruses to streptococcal and other antigens. Sample type strongly affects performance, so the validated swab and collection method matter as much as the cassette.These distinctions decide fitness for purpose. A visually read self-test suits mass screening; a reader-based device with objective interpretation suits a clinic that needs documented, auditable results.Key specifications a buyer must checkLook first at the reported sensitivity and specificity, and crucially the population and viral load in which they were measured, because a test can look excellent in high-load cases and weaker in early or asymptomatic infection. Confirm the validated sample types and the swabs supplied, the time to read and the read window during which the result is valid. Check the storage temperature and shelf life, the operating temperature range, and whether the kit includes everything needed or requires separate buffer and swabs. For reader-based systems, check throughput, connectivity to the record, and whether results can be transmitted to reporting systems. Confirm the intended use covers professional use, self-testing, or both, as regulatory clearance differs.Standards, regulation and reportingA rapid antigen test is an in-vitro diagnostic medical device and must carry valid UKCA or CE marking with a declaration of conformity and instructions for use stating the validated sample types and intended user. Self-tests carry additional lay-user validation. Any reader falls under the IEC 60601-1 or relevant IVD electrical-safety and performance standards, and services align point-of-care quality with ISO 22870. The MHRA regulates in-vitro diagnostics in the UK and operates device registration and safety reporting, with public-health guidance from GOV.UK and the NHS, and international context from the WHO. Confirm Great Britain registration and check any notifiable-disease reporting duties that apply to positive results.Quality control, storage and maintenanceEach lateral-flow test carries a built-in procedural control line that must appear for a valid result, but that does not replace batch quality control. Verify new lots with known positive and negative control material where your governance requires it, and log the checks. Storage is the biggest practical risk: keep kits within the stated temperature range and let refrigerated stock reach room temperature before use, because a cold cassette flows poorly and can misread. Observe expiry dates strictly and do not use a kit whose buffer has been opened beyond its stability window. Reader-based systems need periodic function checks, software updates and cleaning of the optical path per the manufacturer’s schedule.Consumables, decontamination and single-use handlingRapid antigen testing is inherently single-use: the cassette, swab, extraction buffer and tube are all disposable and lot-controlled, and they are the whole running cost. There is no reusable sample path to decontaminate, but surfaces and any reader housing are wiped with a manufacturer-approved disinfectant between uses. Used swabs, cassettes and buffer are potentially infectious and must be handled as clinical waste under workplace-safety duties within the HSE framework, with appropriate personal protective equipment for the sample and setting. Buffer spillage and cross-contamination between samples are the common process errors, so bench discipline matters.Use across care settingsRapid antigen tests are used at the point of care in GP surgeries and A&E for respiratory and streptococcal testing, in care homes and community settings for outbreak control, in occupational-health and mass-screening programmes, and as self-tests at home. A high-throughput clinic values a reader that documents and transmits results; a screening programme values the lowest cost per visually read test; a care home values simplicity and clear instructions for non-laboratory staff. Veterinary practice uses analogous antigen assays. Matching device and format to the setting avoids buying reader capacity a self-test programme will not use, or deploying subjective visual tests where an auditable clinic result is required.Total cost of ownership, warranty and sparesThe economics are dominated by the per-test kit price at your expected volume, so negotiate kit pricing and confirm shelf life and supply continuity to avoid waste and stock-outs. For reader-based systems add the instrument cost, any connectivity or middleware licence, printer paper and consumables, and the warranty and loan-unit terms. Factor staff training and the cost of confirmatory laboratory testing where policy requires positives or negatives to be confirmed. A cheap test that misses cases or needs frequent confirmation is not cheap in practice. Our team can help you compare rapid antigen platforms and kits against your testing volumes and governance — register as a buyer or contact us to discuss options.Procurement checklistMatch sensitivity, specificity and validated sample types to your clinical purpose and patient population.Decide between visually read cassettes and reader-based devices based on documentation and interpretation needs.Confirm UKCA or CE marking, GB registration, intended user and instructions for use.Check storage temperature, shelf life, read window and whether swabs and buffer are included.Verify built-in control lines plus any lot quality-control and confirmatory-testing policy.Confirm reader connectivity and any notifiable-disease reporting duties for positive results.Price kits at your annual volume and confirm shelf life and supply continuity.ConclusionRapid antigen testing gives fast, low-cost detection at the point of care, but devices are far from interchangeable: sensitivity, sample type, reading method and regulatory status all vary. The right choice depends on the clinical question, the population and whether results must be documented and transmitted. Verify the performance data, respect storage and quality control, and cost the kits at real volume. MediGear can supply suitable rapid antigen platforms and consumables so your service tests appropriately and buys with clear eyes.DisclaimerThis article is for informational purposes only. It is published by MediGear (medigear.uk) for general information and procurement guidance, and is not clinical, diagnostic, treatment, technical, engineering, legal or regulatory advice, nor a product endorsement, guarantee or substitute for professional assessment. MediGear does not provide medical consultations. Buyers should consult their clinical, biomedical, estates and regulatory contacts, and the manufacturer's documentation, and independently verify all specifications, certifications, compatibility and suitability before purchase. Specifications, certifications and availability are correct at the time of publication and may change without notice. MediGear is a medical-equipment distributor and does not sell medicines or pharmaceutical products.
